FDA.reportPublic FDA data

pasireotide LAR 10 MG Injection

RxCUI
2049734
RxNorm name
pasireotide LAR 10 MG Injection
Display name
pasireotide LAR 10 MG Injection
Full name
pasireotide LAR 10 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Signifor LARPASIREOTIDERecordati Rare Diseases, Inc.a0aad470-3f38-af97-e053-2995a90a383a2024-07-16Warnings, Adverse reactionsExact identifier
rxcui: 2049734

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a0aad470-3f38-af97-e053-2995a90a383apasireotide LAR 10 MG Injection [PSN] · pasireotide 10 MG Injection [SCD] · pasireotide LAR (as pasireotide pamoate) 10 MG Injection [SY]317These highlights do not include all the information needed to use SIGNIFOR LAR safely and effectively. See full prescribing information for SIGNIFOR LAR. SIGNIFOR ® LAR (pasireotide) for injectable suspension, for intramuscular use Initial U.S. Approval: 201220240716